At AstraZeneca, we consider the value of our medicines to patients and to society as a whole to be at the heart of our corporate responsibility effort.

We focus our resources on six therapy areas where we believe our skills and experience can make the most difference - cancer, cardiovascular, gastrointestinal, infection, neuroscience and respiratory / inflammation. We have a broad product portfolio targeted at these important areas of healthcare, which together represent the majority of the worldwide burden of disease. And we are committed to continued innovation that adds value for all those who benefit from our business.

Innovation drives progress in society and in the case of pharmaceuticals, innovative medicines not only bring benefits for patients, improving health and quality of life for millions of people worldwide, they also create wealth and contribute to the economic development of the communities we serve.

The content of this page was externally assured by Bureau Veritas, February 2008